Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
WellTheory Raises $14M Series A Led by General Catalyst
Series AVenture Capital

WellTheory Raises $14M Series A Led by General Catalyst

•October 15, 2025
•Oct 15, 2025
0

Participants

WellTheory

WellTheory

company

General Catalyst

General Catalyst

investor

7wireVentures

7wireVentures

investor

Ingeborg Investments

Ingeborg Investments

investor

Accel

Accel

investor

Bayer

Bayer

investor

BoxGroup

BoxGroup

investor

Deal Summary

WellTheory, a San Francisco-based whole-person care platform for autoimmune disease, raised $14M in a Series A round led by General Catalyst with participation from 7wire Ventures, Ingeborg Investments, Accel, Box Group, Leaps by Bayer and Up2 Opportunity Fund. The round brings the company’s total funding to $26.2M.

0

Comments

Want to join the conversation?

Loading comments...